user Sign In

QYResearch Account

Manage your Account and Access Personalized Content.

Sign in

Create Account with us

Manage your Account and Access Personalized Content.

Sign Up
       
  
×

Global In-Situ Hybridization Market Overview and Outlook Report 2019

Published Date: 2019-02-11   |   Pages: 104   |   Tables: 113   | Report Id: 991472   | Hits: 3 |   Pharma & Healthcare



In Situ Hybridization (ISH)

In Situ Hybridization (ISH) is a technique that allows for precise localization of a specific segment of nucleic acid within a histologic section.

The underlying basis of ISH is that nucleic acids, if preserved adequately within a histologic specimen, can be detected through the application of a complementary strand of nucleic acid to which a reporter molecule is attached.

Visualization of the reporter molecule allows to localize DNA or RNA sequences in a heterogeneous cell populations including tissue samples and environmental samples. Riboprobes also allow to localize and assess degree of gene expression. The technique is particularly useful in neuroscience.

The global In-Situ Hybridization market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.

This report focuses on In-Situ Hybridization volume and value at global level, regional level and company level. From a global perspective, this report represents overall In-Situ Hybridization market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.

At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:

Abbott Laboratories

F. Hoffmann-La Roche

Leica Biosystems Nussloch

Agilent Technologies

Thermo Fisher Scientific

Merck

PerkinElmer

Exiqon A/S

BioGenex Laboratories

Advanced Cell Diagnostics

Bio SB

Segment by Regions

North America

Europe

China

Japan

Segment by Type

Radioactive isotopes

Non-radioactive labels

Segment by Application

Cancer Diagnosis

Immunology

Neuroscience

Cytology

Infectious Diseases

Licenses Type

Only one user can access the report
Multiple users can access the report

Why QYR

 Fastest report delivery service
 More than 10 years of vast experience
 Operational for 24 * 7 & 365 days
 In-depth and comprehensive analysis
 Excellent after sales support
 Owns large database

Need Help ?

QYR Clients

More Clients...